Abstract
Background:
Dual mobility components in total hip arthroplasty have been successfully in use in Europe for greater than 25 years. However, these implants have only recently obtained FDA approval and acceptance among North American arthroplasty surgeons. Both decreased dislocation rate and decreased wear rates have been proposed benefits of dual mobility components. These components have been used for primary total hip arthroplasty in patients at high risk for dislocation, total hip arthroplasty in the setting of femoral neck fracture, revision for hip instability, and revision for large metal-on-metal (MoM) hip articulation. The literature for the North American experience is lacking.
Purpose:
We report indications, short term outcomes, and complications of a series of subjects who received dual mobility outcomes at one institution.
Study Design:
Consecutive subjects who received dual mobility total hip arthroplasty components from February 2010 and April 2013 were identified. Charts were retrospectively reviewed for surgical indications, comorbidities, component sizes, and perioperative complications including infection, dislocation, mechanical failure, and reoperation.
Results:
86 hips in 83 subjects underwent total hip arthroplasty or revision total hip arthroplasty using dual mobility components. There were 56 primary total hips and 30 revision total hips. Indications included small acetabular components in the setting of AVN (13 hips), DDH (12 hips) or severe inflammatory arthritis (5 hips), femoral neck fracture (5 hips), intraoperative instability (6 hips), recurrent postoperative instability (5 hips), and revision of large MoM articulations in the setting of failed hip resurfacing (10 hips) or failed MoM total hip arthroplasty (6 hips). Mean follow up was 1 year (3 months to 3.3 years). There were no complications in the primary total hip group. In the revision total hip group, only one hip dislocated and this was in a patient with familial dysautonomia and insensitivity to pain. One subject underwent reoperation for acute prosthetic joint infection. No other complications were encountered. Overall dislocation rate was 1.1% and overall complication rate was 2.2%.
Conclusions:
These results closely mirror that of the European literature. Dual mobility articulations in total hip arthroplasty have a low short term complication rate in this cohort and provide a simple solution to difficult cases. Indications for these implants include primary and revision total hip arthroplasty in patients at high risk for instability and revision of large MoM implants including hip resurfacing.
